Last reviewed · How we verify
NCT05926752: PMPP
Photobiomodulation for Myofascial Pelvic Pain
NA trial testing SoLá therapy in Pelvic Pain in 28 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Orlando VA Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 27 October 2021 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SoLá therapy
- Pelvic floor physical therapy
Conditions studied
- Pelvic Pain — all drugs for Pelvic Pain →
- Levator Ani Syndrome — all drugs for Levator Ani Syndrome →
- Spastic Pelvic Floor Syndrome — all drugs for Spastic Pelvic Floor Syndrome →
- Chronic Pelvic Pain Syndrome — all drugs for Chronic Pelvic Pain Syndrome →
Sponsor
Orlando VA Medical Center
Who can join
18 and older, female only, with Pelvic Pain or Levator Ani Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the efficacy of photobiomodulation of the pelvic floor muscles in female Veterans with chronic pelvic pain. The main questions it aims to answer are: * Is there a difference in reduction in overall pelvic pain between women who undergo photobiomodulation compared to women who received pelvic floor physical therapy? * Is there a difference in compliance with therapy between the two groups? Participants will be randomized to treatment with either 9 treatments of photobiomodulation (two treatments per week) or 8 weeks of pelvic floor physical therapy (one treatment a week). Researchers will compare both groups to see if there is a difference in overall pelvic pain reduction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Differences in the Effectiveness of Different Physical Therapy Modalities in the Treatment of Delayed-Onset Muscle Soreness: A Systematic Review and Bayesian Network Meta-Analysis.
Chen J, Hu Q, Hu J, Liu S, et al · · 2025 · PMID 40538474 · DOI 10.2147/jpr.s519242
Verify or expand the search:
- PubMed search for NCT05926752
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pelvic Pain
Currently open trials in the same condition.
- NCT07241637 — Effect of Tele-Yoga on Pain, Fatigue, and Quality of Life in Endometriosis · NA · recruiting
- NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
- NCT06921174 — Comparison of the Effectiveness of Classical Perineal Massage Therapy Versus the Use of an Intravaginal Device to Reduce · Phase 2 · recruiting
- NCT06549985 — Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain · NA · recruiting
- NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05926752 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Orlando VA Medical Center
- Last refreshed: 3 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05926752.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing